Physician profile
Christopher Raffo
NPI 1750398905
$19,045.81
in general payments reported to CMS, 2019-2025
12 companies · $1,120 in 2025
The $1,120 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,741 · 2020: $9,545 · 2021: $2,580 · 2022: $2,128 · 2023: $647 · 2024: $285 · 2025: $1,120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,543 · Food and Beverage: $508.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,543.46 |
| Food and Beverage | $508.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $14,571.70 | 2019-2024 | Real Intelligence |
| Supreme Orthopedic Systems, LLC | $2,652.36 | 2020-2025 | |
| Arthrex, INC. | $1,193.00 | 2020-2025 | |
| Stryker Corporation | $292.63 | 2019-2020 | |
| Miach Orthopaedics, INC. | $136.17 | 2024 | |
| Fidia Pharma USA INC. | $53.92 | 2019-2025 | Hymovis, Triluron |
| Zimmer Biomet Holdings, INC. | $45.46 | 2019 | |
| Depuy Synthes Sales INC. | $26.49 | 2025 | Monovisc |
| Bioventus LLC | $26.08 | 2022 | |
| Pacira Therapeutics, INC. | $17.79 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $15.84 | 2023 | Iovera, Zilretta |
| Ermi LLC | $14.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Raffo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.